• The ACA Exchanges: Are Your Medications Really “Essential”?

    PPACA Update by and on September 18th, 2013

    On January 1, 2014, the Affordable Care Act’s (ACA) Exchange Plans will open for business, and millions of Americans will access insurance coverage for the first time. No one yet knows just how many Americans will sign up—recent White House estimates hope for seven million newly-covered lives, although the number could be far greater.1 Either […]

  • How the Affordable Care Act Changes the Patient Journey (Part Three)

    PPACA Update by on August 8th, 2013

    Non-Adherence, Technology and DTC A recent study from Capgemini Consulting found that the pharma industry is losing more than $180 billion due to non-adherence.1 One reason for the leakage between the provider’s office and the pharmacy is an information search by the patient between the writing of the prescription and the dispensing of the prescription. […]

  • How the Affordable Care Act Changes the Patient Journey (Part Two)

    PPACA Update by on July 16th, 2013

    Evidence-Based Medicine Along with creating an increase in healthcare demand and the subsequent provider issues, PPACA also requires providers to practice evidence-based medicine, apply care coordination, discuss preventative health for at risk populations and “follow up” with individuals. Much has been made of the evidence-based medicine requirement, which many feel may be hard to implement. […]

  • How the Affordable Care Act Changes the Patient Journey (Part One)

    PPACA Update by on June 1st, 2013

    Whether you supported it or opposed it, as 2013 unfolds “Obama Care”/ “The Affordable Care Act” will gain momentum as it is fully implemented. The implementation of the law will undoubtedly have significant consequences for the pharmaceutical industry and its associated service providers across the board. But how will it influence the unique challenges marketers […]

  • From Patient Adherence to Patient Centricity

    Feature Articles by on May 1st, 2013

    “What would Apple do in this situation?” This may seem like a common question for marketing circles. Not in pharma. Or, not in pharma until very recently. The industry is starting to look outside for leading practices, at consumer goods, financial services, airlines, etc. Patient adherence experts are hired with increasing frequency for their success […]

  • Last Word of the Sunshine Act: The Art of Compliance After the Final Rule

    Panorama by on March 21st, 2013

    All is finally said and done. Despite some lingering clarifications, the mystery surrounding the Sunshine Act is now over. As of February 1, 2013, the Centers for Medicare & Medicaid Services (CMS) announced the final rule for the provision as part of the Patient Protection and Affordable Care Act (PPACA). The finalized Sunshine Act includes […]

  • Projecting End-to-End Specialty Brand Value

    Feature Articles by and on March 19th, 2013

    In specialty pharma, brand marketers need to integrate distribution with patient services in order to project a clear value throughout the patient journey and ensure a positive experience with the brand. In today’s ever-more-connected, post-PPACA healthcare environment, the patient experience takes center stage. That means brand managers and marketers must consider a product’s journey at […]

  • How the ACA Will Impact Pharma Marketers

    Guest Commentary by on August 1st, 2012

    In the wake of the Supreme Court’s ruling on the Affordable Care Act, the pharmaceutical industry faces some interesting challenges in dealing with the law’s effect on Medicare, Medicaid, and pharma’s relationship with patient-advocacy groups. The recent Supreme Court decision upholding the constitutionality of the Patient Protection and Affordable Care Act (PPACA), also known as […]

  • PM360 Special Section Affordable Care Act—The Right Prescription?

    Feature Articles by on August 1st, 2012

    INDEX ACA–The Right Rx for Pharma and America? ACA–The Physician Perspective: Our Doctors Weigh In American Healthcare Will Be More Egalitarian, By Stephen R. Feldman An Unsustainable Business Model for Primary Care Docs, By Matthew Mintz ACA–How Payers Will Have to Play Under the ACA, By Kim E. White Affordable Care Act: The Right Rx […]

  • Duel: The Press-Release War over PPACA

    Washington Wire by on March 1st, 2012

    Take ten paces, turn, and fire. And fire. And fire. The duel over healthcare reform continues to heat up. The Patient Protection and Affordable Care Act of 2010 (PPACA) came in fourth on a mid-February Gallup poll of the public’s election-year issues: PPACA trailed the economy, unemployment, and the federal deficit, but led terrorism, taxation, […]

  • Washington Wire: Healthcare Reform Gaining Support

    Washington Wire by on February 1st, 2012

    In an announcement that’s bound to be bittersweet for folks who pay taxes in the U.S. and make their livings in the pharmaceutical industry, the Centers for Medicare and Medicaid Services (CMS) estimate that the 2010 Patient Protection and Affordable Care Act (PPACA) “will save taxpayers and States an estimated $17.7 billion over five years […]

  • Aggregating Research Payments from Multiple CROs

    Compliance Center by on February 1st, 2012

    Last month, the Centers for Medicare & Medicaid Services (CMS) published proposed regulations for implementing the Physician Payment Sunshine Act (Sunshine Act) provisions under the Patient Protection and Affordable Care Act (PPACA Section 6002). The proposed regulations reaffirm that manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children’s Health […]

  • NPs and PAs Meet the Challenge of Healthcare Reform

    Feature Articles by on January 1st, 2012

    As professions born in 1965, the Physician Assistant and Nurse Practitioner are moving into middle age. Over five decades, they have changed the way medicine is practiced. To their dismay, they have had less of an impact on the way the pharmaceutical industry disseminates product information to their professions. The barriers continue to fall, however. […]

Back to top